CN102100650A - 一种防治褥疮用的凝胶医疗用品及其制备方法 - Google Patents
一种防治褥疮用的凝胶医疗用品及其制备方法 Download PDFInfo
- Publication number
- CN102100650A CN102100650A CN 201110031794 CN201110031794A CN102100650A CN 102100650 A CN102100650 A CN 102100650A CN 201110031794 CN201110031794 CN 201110031794 CN 201110031794 A CN201110031794 A CN 201110031794A CN 102100650 A CN102100650 A CN 102100650A
- Authority
- CN
- China
- Prior art keywords
- gel
- water
- decubital ulcer
- treat
- distilled water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 208000004210 Pressure Ulcer Diseases 0.000 title abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000012153 distilled water Substances 0.000 claims abstract description 39
- 239000004744 fabric Substances 0.000 claims abstract description 29
- 229920001661 Chitosan Polymers 0.000 claims abstract description 28
- 238000010438 heat treatment Methods 0.000 claims abstract description 28
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical group C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000004094 surface-active agent Substances 0.000 claims abstract description 23
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 18
- 239000003974 emollient agent Substances 0.000 claims abstract description 15
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 13
- 208000025865 Ulcer Diseases 0.000 claims description 64
- 231100000397 ulcer Toxicity 0.000 claims description 64
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- 239000002253 acid Substances 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 27
- -1 polypropylene Polymers 0.000 claims description 24
- 239000004743 Polypropylene Substances 0.000 claims description 23
- 229920001155 polypropylene Polymers 0.000 claims description 23
- 239000011347 resin Substances 0.000 claims description 23
- 229920005989 resin Polymers 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 18
- 230000002269 spontaneous effect Effects 0.000 claims description 17
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 14
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 14
- 239000011259 mixed solution Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 11
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 11
- OYVWNCFVPCTLFI-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)NCCN(CC)CC Chemical compound C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)NCCN(CC)CC OYVWNCFVPCTLFI-UHFFFAOYSA-N 0.000 claims description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 229940123208 Biguanide Drugs 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 238000013019 agitation Methods 0.000 claims description 9
- 150000004283 biguanides Chemical class 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 230000002101 lytic effect Effects 0.000 claims description 9
- 229960003975 potassium Drugs 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 239000004745 nonwoven fabric Substances 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229920003169 water-soluble polymer Polymers 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229960005069 calcium Drugs 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- BEGBSFPALGFMJI-UHFFFAOYSA-N ethene;sodium Chemical group [Na].C=C BEGBSFPALGFMJI-UHFFFAOYSA-N 0.000 claims description 5
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 5
- QBKSIHCSDPPLJI-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]tetradecan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC(CO)N(CCO)CCO QBKSIHCSDPPLJI-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 4
- 229920002413 Polyhexanide Polymers 0.000 claims description 4
- 235000009392 Vitis Nutrition 0.000 claims description 4
- 241000219095 Vitis Species 0.000 claims description 4
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims description 4
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims description 4
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- 235000011083 sodium citrates Nutrition 0.000 claims description 4
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 239000003945 anionic surfactant Substances 0.000 claims description 3
- 229960002152 chlorhexidine acetate Drugs 0.000 claims description 3
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims description 2
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 claims description 2
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- 235000012677 beetroot red Nutrition 0.000 claims description 2
- 239000001654 beetroot red Substances 0.000 claims description 2
- 235000002185 betanin Nutrition 0.000 claims description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 2
- 239000001354 calcium citrate Substances 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- GUPPESBEIQALOS-ZVGUSBNCSA-L calcium;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Ca+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O GUPPESBEIQALOS-ZVGUSBNCSA-L 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 claims description 2
- 239000001508 potassium citrate Substances 0.000 claims description 2
- 229960002635 potassium citrate Drugs 0.000 claims description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 2
- 235000011082 potassium citrates Nutrition 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 claims description 2
- 239000000176 sodium gluconate Substances 0.000 claims description 2
- 235000012207 sodium gluconate Nutrition 0.000 claims description 2
- 229940005574 sodium gluconate Drugs 0.000 claims description 2
- 239000001433 sodium tartrate Substances 0.000 claims description 2
- 229960002167 sodium tartrate Drugs 0.000 claims description 2
- 235000011004 sodium tartrates Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 238000004140 cleaning Methods 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 206010061218 Inflammation Diseases 0.000 abstract description 7
- 241000894006 Bacteria Species 0.000 abstract description 4
- 239000003899 bactericide agent Substances 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 239000004753 textile Substances 0.000 abstract 3
- 230000004060 metabolic process Effects 0.000 abstract 2
- NTTLKRPWPKPUAI-UHFFFAOYSA-N (1e)-1-[amino(anilino)methylidene]-2-phenylguanidine Chemical group C=1C=CC=CC=1N=C(N)\N=C(/N)NC1=CC=CC=C1 NTTLKRPWPKPUAI-UHFFFAOYSA-N 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 18
- 230000003203 everyday effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 238000007920 subcutaneous administration Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 206010011985 Decubitus ulcer Diseases 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000228197 Aspergillus flavus Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 208000007875 Femur Head Necrosis Diseases 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000589540 Pseudomonas fluorescens Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000000721 bacterilogical effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 210000002659 acromion Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000954 sacrococcygeal region Anatomy 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical class [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
序号 | 理化技术指标 | 单位 | 量值 |
1 | 装量 | g | 60g/瓶 |
2 | 粘度 | Pa.s/m | ≥10 |
3 | pH值 | / | 6.5 |
4 | 发热温度 | ℃ | 40 |
检测项目 | 检测标准 | 检测结果 | 结论 |
细菌总数 | 0 | 0 | 合格 |
金黄色葡萄球菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
大肠杆菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
绿脓杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
产气杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
粪产杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
荧光假单胞菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
黄曲霉菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
变形杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
枯草芽孢杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
白色念珠菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
乙肝表面抗原 | 杀灭率≥99.9% | 100% | 合格 |
序号 | 检测项目 | 单位 | 量值 |
1 | 远红外发射波长 | μm | 8-15 |
2 | 法向全发射率 | 无 | 0.84 |
序号 | 理化技术指标 | 单位 | 量值 |
1 | 装量 | g | 50g/袋 |
2 | 粘度 | Pa.s/m | ≥12 |
3 | pH值 | / | 6.2 |
4 | 发热温度 | ℃ | 42 |
检测项目 | 检测标准 | 检测结果 | 结论 |
细菌总数 | 0 | 0 | 合格 |
金黄色葡萄球菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
大肠杆菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
绿脓杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
产气杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
粪产杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
荧光假单胞菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
黄曲霉菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
变形杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
枯草芽孢杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
白色念珠菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
乙肝表面抗原 | 杀灭率≥99.9% | 100% | 合格 |
序号 | 检测项目 | 单位 | 量值 |
1 | 远红外发射波长 | μm | 8-15 |
2 | 法向全发射率 | 无 | 0.84 |
序号 | 理化技术指标 | 单位 | 量值 |
1 | 装量 | g | 50g/袋 |
2 | 粘度 | Pa.s/m | ≥11 |
3 | pH值 | / | 6.1 |
4 | 发热温度 | ℃ | 39 |
检测项目 | 检测标准 | 检测结果 | 结论 |
细菌总数 | 0 | 0 | 合格 |
金黄色葡萄球菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
大肠杆菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
绿脓杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
产气杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
粪产杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
荧光假单胞菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
黄曲霉菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
变形杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
枯草芽孢杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
白色念珠菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
乙肝表面抗原 | 杀灭率≥99.9% | 100% | 合格 |
序号 | 检测项目 | 单位 | 量值 |
1 | 远红外发射波长 | μm | 8-15 |
2 | 法向全发射率 | 无 | 0.83 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110031794 CN102100650B (zh) | 2011-01-28 | 2011-01-28 | 一种防治褥疮用的凝胶医疗用品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110031794 CN102100650B (zh) | 2011-01-28 | 2011-01-28 | 一种防治褥疮用的凝胶医疗用品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102100650A true CN102100650A (zh) | 2011-06-22 |
CN102100650B CN102100650B (zh) | 2013-06-19 |
Family
ID=44153851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110031794 Expired - Fee Related CN102100650B (zh) | 2011-01-28 | 2011-01-28 | 一种防治褥疮用的凝胶医疗用品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102100650B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102423249A (zh) * | 2011-11-25 | 2012-04-25 | 铜陵洁雅生物科技股份有限公司 | 一种祛臭防褥疮医用护理湿巾及其制备方法 |
CN105342939A (zh) * | 2015-12-15 | 2016-02-24 | 山东消博士消毒科技股份有限公司 | 可降低手术切口感染的消毒沐浴液及其制备工艺 |
CN106606425A (zh) * | 2016-11-18 | 2017-05-03 | 上海市质量监督检验技术研究院 | 一种抗菌保湿组合物及其制备方法和应用 |
CN106750578A (zh) * | 2016-12-16 | 2017-05-31 | 吴中区穹窿山天仲高分子材料技术研究所 | 一种抗菌高分子材料 |
CN108524739A (zh) * | 2018-06-26 | 2018-09-14 | 西安艾姆高分子材料有限公司 | 一种治疗褥疮的凝胶药剂 |
CN108939130A (zh) * | 2017-05-21 | 2018-12-07 | 衢州玛济克医疗科技有限公司 | 一种褥疮医用敷料及其生产方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1960736A (zh) * | 2004-02-27 | 2007-05-09 | 海德罗默公司 | 抗感染水凝胶组合物 |
-
2011
- 2011-01-28 CN CN 201110031794 patent/CN102100650B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1960736A (zh) * | 2004-02-27 | 2007-05-09 | 海德罗默公司 | 抗感染水凝胶组合物 |
Non-Patent Citations (1)
Title |
---|
《中国组织工程研究与临床康复》 20100115 柯林楠等 医用敷料研究的现状与进展 521-524 1-11 第14卷, 第3期 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102423249A (zh) * | 2011-11-25 | 2012-04-25 | 铜陵洁雅生物科技股份有限公司 | 一种祛臭防褥疮医用护理湿巾及其制备方法 |
CN105342939A (zh) * | 2015-12-15 | 2016-02-24 | 山东消博士消毒科技股份有限公司 | 可降低手术切口感染的消毒沐浴液及其制备工艺 |
CN106606425A (zh) * | 2016-11-18 | 2017-05-03 | 上海市质量监督检验技术研究院 | 一种抗菌保湿组合物及其制备方法和应用 |
CN106750578A (zh) * | 2016-12-16 | 2017-05-31 | 吴中区穹窿山天仲高分子材料技术研究所 | 一种抗菌高分子材料 |
CN108939130A (zh) * | 2017-05-21 | 2018-12-07 | 衢州玛济克医疗科技有限公司 | 一种褥疮医用敷料及其生产方法 |
CN108524739A (zh) * | 2018-06-26 | 2018-09-14 | 西安艾姆高分子材料有限公司 | 一种治疗褥疮的凝胶药剂 |
Also Published As
Publication number | Publication date |
---|---|
CN102100650B (zh) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102100650B (zh) | 一种防治褥疮用的凝胶医疗用品及其制备方法 | |
CN101953860B (zh) | 一种缓解痔疮症状的湿巾及其生产方法 | |
CN102091097B (zh) | 一种免冲洗产妇会阴医疗护理凝胶及其制备方法 | |
CN102988231B (zh) | 一种女性护理液及其制备方法 | |
CN102961286A (zh) | 一种卫生消毒湿巾及其制备方法 | |
CN101829041A (zh) | 一种杀菌止痒的妇科洗液 | |
CN102940583A (zh) | 一种可作为营养面膜的温敏水凝胶及其制备方法 | |
CN103565692A (zh) | 一种含有多种植物提取物的清洗护理液及其制作工艺 | |
CN102113981B (zh) | 一种免冲洗孕妇会阴医疗护理凝胶及其制备方法 | |
CN107987530A (zh) | 负载石墨烯二氧化钛纳米银电气石磁粉的硅胶制品 | |
CN106309401A (zh) | 一种用于预防和治疗皮肤疾病的沐浴泡腾片 | |
CN102090968A (zh) | 免冲洗头部医疗护理品及制备方法 | |
JP2018521992A5 (zh) | ||
CN109303742A (zh) | 一种抑菌护理液及其制备方法 | |
CN101439201A (zh) | 一种医护消毒柔湿巾 | |
CN105616296B (zh) | 一种杨枸花止痒护肤泥 | |
CN104586899A (zh) | 一种治疗褥疮的气雾剂及其制备方法 | |
CN102767078A (zh) | 特殊工艺整理壳聚糖抗菌防臭保健袜 | |
CN105769640A (zh) | 一种大蒜油活性保洁洗手液 | |
CN108743911A (zh) | 一种灭菌养护剂 | |
CN103157128A (zh) | 一种日用保健品及其制作方法 | |
KR20070078753A (ko) | 알로에와 마늘을 이용한 보건제의 개선된 제조방법. | |
CN101244130A (zh) | 一种防止创伤皮肤瘢痕的复方蜈蚣酒精药糊 | |
CN108294997A (zh) | 天然物质复合抗菌面膜粉、面膜及制备方法 | |
CN105169463A (zh) | 一种阳离子婴儿医用敷料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Gel medical product for preventing bedsore and preparation method thereof Effective date of registration: 20211216 Granted publication date: 20130619 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Wuhan Coupling Medicine Technology Co.,Ltd. Registration number: Y2021420000144 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230403 Granted publication date: 20130619 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Wuhan Coupling Medicine Technology Co.,Ltd. Registration number: Y2021420000144 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130619 |
|
CF01 | Termination of patent right due to non-payment of annual fee |